ResMed Inc. vs Veritone Inc — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Veritone Inc trades at $1.13 (market cap $97.60M). The key difference: ResMed Inc. is far larger — about 295.2× Veritone Inc's market cap, and ResMed Inc. pays a 1.21% dividend while Veritone Inc pays none. Which is the better fit depends on your goals.
| RMD | VERI | |
|---|---|---|
Market Cap | $28.81B | $97.60M |
Sector | Health | Technology |
52-Week High | $293.73 | $8.39 |
52-Week Low | $182.82 | $1.02 |
Enterprise Value | $27.99B | $129.63M |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →